Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
暂无分享,去创建一个
A. Traboulsee | S. Meuth | G. Pardo | L. Massacesi | D. Compston | C. Ionete | Zia Choudhry | R. Simm | D. Mitsikostas | A. Bass | R. Berkovich | N. Daizadeh | B. Steingo | Ó. Fernández | Y. Al Malik | M. Carraro